Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
machineMD’s neos® device is already in clinical use in Switzerland and the United States. It enables fast, automated, quantitative assessment of oculomotor and pupillary activity using virtual reality technology combined with AI-driven analytics. The company is conducting targeted studies on conditions such as Parkinson’s disease, Alzheimer’s disease, and Multiple Sclerosis to further validate its technology for broader screening applications. Early results highlight reliable gaze measurements and streamlined workflows that support scalable neurodiagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on machineMD.